Digestive and Liver Disease
Volume 42, Issue 8 , Pages 571-577 , August 2010

Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase

  • Giuseppe D’Argenio

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Medicina Clinica e Sperimentale, Gastroenterologia, Facoltà di Medicina, Università Federico II, Via Pansini, 5, 80131, Napoli, Italy. Tel.: +39 081 7462706; fax: +39 081 7462739.
    • ,
  • Daniela Caterina Amoruso

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    • ,
  • Giovanna Mazzone

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    • ,
  • Paola Vitaglione

      Affiliations

    • Department of Food Science, Federico II University, Naples, Italy
    • ,
  • Antonietta Romano

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    • ,
  • Maria Teresa Ribecco

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    • ,
  • Maria Rosaria D’Armiento

      Affiliations

    • Department of Biomorphological Science, Federico II University, Naples, Italy
    • ,
  • Ernesto Mezza

      Affiliations

    • Department of Biomorphological Science, Federico II University, Naples, Italy
    • ,
  • Filomena Morisco

      Affiliations

    • Department of Food Science, Federico II University, Naples, Italy
    • ,
  • Vincenzo Fogliano

      Affiliations

    • Department of Food Science, Federico II University, Naples, Italy
    • ,
  • Nicola Caporaso

      Affiliations

    • Gastroenterology Unit, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy

Received 24 July 2009 ,Accepted 4 November 2009.

References 

  1. Török NJ. Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol. 2008;43:315–321
  2. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med. 2000;124:1599–1607
  3. Benyon RC, Iredale JP. Is liver fibrosis reversible?. Gut. 2000;46:443–446
  4. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538–549
  5. Iredale JP. Hepatic stellate cell behaviour during resolution of liver injury. Semin Liver Dis. 2001;21:427–436
  6. Elli L, Bergamini CM, Bardella MT, et al. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis. 2009;41:541–550
  7. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. Fed Am Soc Exp Biol J. 1992;5:3071–3077
  8. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993;121:439–448
  9. Lorand L. Neurodegenerative diseases and transglutaminase. Proc Natl Acad Sci U S A. 1997;93:14310–14313
  10. Ikura K, Takahata K, Sasaki Y. Cross-linking of a synthetic partial length (1–28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase. FEBS Lett. 1993;326:109–111
  11. Lesort M, Tucholski J, Miller ML, et al. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol. 2000;61:439–463
  12. Dedeoglu A, Kubilus JK, Jeitner TM, et al. Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci. 2002;22:8942–8950
  13. Qiu J-F, Zhang Z-Q, Chen W, et al. Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. World J Gastroenterol. 2007;28:4328–4332
  14. Jeitner TM, Delikatny EJ, Ahlqvist J, et al. Mechanism for the inhibition of transglutaminase 2 by cystamine. Biochem Pharmacol. 2005;69:961–970
  15. Dubinsky R, Gray C. CYTE-I-HD Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease. Mov Disord. 2006;21:530–533
  16. Tapiero H, Townsend DM, Tew KD. Organosulfur compounds from alliaceae in the prevention of human pathologies. Biomed Pharmacother. 2004;58:183–193
  17. Borek C. Antioxidant health effects of aged garlic extract. J Nutr. 2001;131:1010S–1015S
  18. Singleton VL, Rossi JA. Colourimetry of total phenolics with phosphomolybdic–phosphotungstic acid reagents. Am J Enol Viticult. 1965;16:144–158
  19. Issa R, Zhou X, Trim N, et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J. 2003;17:47–49
  20. Lorand L, Campbell-Wilkes LK, Cooperstein L. A filter paper assay for transamidating enzyme using radioactive amine substrate. Ann Biochem. 1972;50:623–631
  21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685
  22. Grenard P, Bresson-Hadni S, Alaoui SE, et al. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol. 2001;35:367–375
  23. Karpuj MV, BecherMW , Springer JE, et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med. 2002;8:143–149
  24. Lesort M, Lee M, Tucholski J, et al. Cystamine inhibits caspase activity. Implication for the treatment of polyglutamine disorders. J Biol Chem. 2003;278:3825–3830
  25. Chang ML, Klaidman LK, Adams JD. The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice. Mol Chem Neuropathol. 1997;30:187–197
  26. Gedik N, Kabasakal L, Şehirli Ö, et al. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci. 2005;76:2593–2606
  27. Amagase H, Petesch B, Matsuura H, et al. Intake of garlic and its bioactive components. J Nutr. 2001;131:955S–962S
  28. Powolny A, Singh SV. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett. 2008;269:305–314
  29. Kritchevsky D. The effect of dietary garlic on the development of cardiovascular disease. Trends Food Sci Technol. 1991;2:141–144
  30. Ackerman R, Mulrow CD, Ramirez G, et al. Garlic shows promise for improving some cardiovascular risk factors. Arch Int Med. 2001;161:813–824
  31. Egen-Schwind C, Eckard R, Kemper FH. Metabolism of garlic constituents in the isolated perfused rat liver. Planta Med. 1992;58:301–305

PII: S1590-8658(09)00437-X

doi: 10.1016/j.dld.2009.11.002

Digestive and Liver Disease
Volume 42, Issue 8 , Pages 571-577 , August 2010

Article Tools

* Image Usage & Resolution